Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients

J Heart Lung Transplant 2021;40(4).

(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824 · see citing works

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360 · see citing works

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells

Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni1009 · Cited by 1,830 · see citing works

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635 · see citing works

Infection in Organ-Transplant Recipients

Fishman, J. A., & Rubin, R. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382407 · Cited by 1,635 · see citing works

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

Appay, V., Dunbar, P. R., Callan, M. F. C., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,556 · see citing works

The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol

Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M. S., Geuze, H. J., & Ploegh, H. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81054-5 · Cited by 1,073 · see citing works

A Role for CD40 Expression on CD8 + T Cells in the Generation of CD8 + T Cell Memory

Bourgeois, C., Rocha, B., & Tanchot, C. (2002) · Science · doi:10.1126/science.1072615 · Cited by 641 · see citing works

Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients

Snydman, D. R., Werner, B. G., Heinze-Lacey, B., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171703 · Cited by 580 · see citing works

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants

Limaye, A. P., Corey, L., Koelle, D. M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02607-6 · Cited by 513 · see citing works

Primary immune responses to human CMV: a critical role for IFN-γ–producing CD4+ T cells in protection against CMV disease

Gamadia, L. E., Remmerswaal, E. B. M., Weel, J. F. L., Bemelman, F. J., van Lier, R. A. W., & ten Berge, I. J. M. (2003) · Blood · doi:10.1182/blood-2002-08-2502 · Cited by 423 · see citing works

Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus

Wang, X., Huong, S., Chiu, M. L., Raab‐Traub, N., & Huang, E. (2003) · Nature · doi:10.1038/nature01818 · Cited by 417 · see citing works

Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo

Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396 · see citing works

Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder

Walker, R. C., Marshall, W. F., Strickler, J. G., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1346 · Cited by 396 · see citing works

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376 · see citing works

Emergence of a CD4+CD28− Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection

van Leeuwen, E. M. M., Remmerswaal, E. B. M., Vossen, M. T. M., Rowshani, A. T., Dillen, P. M. E. W., van Lier, R. A. W., & ten Berge, I. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1834 · Cited by 369 · see citing works

Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10

Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., & Schall, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1285-1292.2002 · Cited by 322 · see citing works

Human CD8+ T-cell differentiation in response to viruses

van Lier, R. A. W., ten Berge, I. J. M., & Gamadia, L. E. (2003) · Nature Reviews Immunology · doi:10.1038/nri1254 · Cited by 297 · see citing works

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

Mocarski, E. S. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02393-4 · Cited by 291 · see citing works

Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited

Kern, F., Surel, I. P., Faulhaber, N., Frömmel, C., Schneider‐Mergener, J., Schönemann, C., Reinke, P., & Volk, H. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8179-8184.1999 · Cited by 277 · see citing works

Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

Hibberd, P. L., TOLKOFF-RUBIN, N. E., Conti, D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-1-199507010-00002 · Cited by 258 · see citing works

The Indirect Effects of Cytomegalovirus Infection on the Outcome of Organ Transplantation

Rubin, R. H. (1989) · JAMA · doi:10.1001/jama.1989.03420240121038 · Cited by 234 · see citing works

SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2

Hibberd, P. L., TOLKOFF-RUBIN, N. E., Cosimi, A. B., et al. (1992) · Transplantation · doi:10.1097/00007890-199201000-00013 · Cited by 230 · see citing works

Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir

Razonable, R. R., Rivero, A., Rodriguez, A., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/324516 · Cited by 230 · see citing works

CMV INFECTION, CLASS II ANTIGEN EXPRESSION, AND HUMAN KIDNEY ALLOGRAFT REJECTION

von Willebrand, E., Pettersson, E. E., Ahonen, J. P., et al. (1986) · Transplantation · doi:10.1097/00007890-198610000-00006 · Cited by 221 · see citing works

Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers

Gamadia, L. E., Rentenaar, R. J., Baars, P. A., Remmerswaal, E. B. M., Surachno, S., Weel, J. F. L., Toebes, M., Schumacher, T. N., ten Berge, I. J. M., & van Lier, R. A. W. (2001) · Blood · doi:10.1182/blood.v98.3.754 · Cited by 215 · see citing works

Targeting the Function of Mature Dendritic Cells by Human Cytomegalovirus

Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., & Schönrich, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00239-4 · Cited by 208 · see citing works

Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal Transplant

Plotkin, S. A., Starr, S. E., Friedman, H. M., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-525 · Cited by 200 · see citing works

A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection

Jenkins, C., Abendroth, A., & Slobedman, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1440-1447.2004 · Cited by 188 · see citing works

Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients

Limaye, A. P. (2002) · Clinical Infectious Diseases · doi:10.1086/342385 · Cited by 187 · see citing works

Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein

Rölle, A., Mousavi‐Jazi, M., Eriksson, M., Odeberg, J., Söderberg‐Nauclér, C., Cosman, D. J., Kärre, K., & Cerboni, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.902 · Cited by 185 · see citing works

A review of genetic differences between limited and extensively passaged human cytomegalovirus strains

Prichard, M. N., Penfold, M. E. T., Duke, G. M., et al. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.315 · Cited by 177 · see citing works

MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSION

HADLEY, S., SAMORE, M. H., LEWIS, W. D., Jenkins, R. L., Karchmer, A. W., & Hammer, S. M. (1995) · Transplantation · doi:10.1097/00007890-199503000-00009 · Cited by 176 · see citing works

Development of virus-specific CD4+ T cells during primary cytomegalovirus infection

Rentenaar, R. J., Gamadia, L. E., van derHoek, N., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8229 · Cited by 172 · see citing works

Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV

Kuijpers, T. W., Vossen, M. T. M., Gent, M.-R., Davin, J. C., Roos, M. T. L., Dillen, P. M. E. W., Weel, J. F. L., Baars, P. A., & van Lier, R. A. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4342 · Cited by 169 · see citing works

Infections and solid organ transplant rejection: a cause-and-effect relationship?

Cainelli, F., & Vento, S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00370-5 · Cited by 162 · see citing works

Diagnosis and treatment approaches of CMV infections in adult patients

de la Hoz, R. E., Stephens, G. M., & Sherlock, C. H. (2002) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00091-4 · Cited by 161 · see citing works

Preemptive Therapy in Immunocompromised Hosts

Rubin, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241509 · Cited by 157 · see citing works

Epidemiology and Management of Infections after Lung Transplantation

Speich, R., & van der Bij, W. (2001) · Clinical Infectious Diseases · doi:10.1086/320906 · Cited by 157 · see citing works

Proliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T Cells

van Leeuwen, E. M. M., Gamadia, L. E., Baars, P. A., Remmerswaal, E. B. M., ten Berge, I. J. M., & van Lier, R. A. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5838 · Cited by 147 · see citing works

MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS VACCINE IN SERONEGATIVE RENAL TRANSPLANT RECIPIENTS

Plotkin, S. A., Higgins, R. M., Kurtz, J. B., et al. (1994) · Transplantation · doi:10.1097/00007890-199412000-00006 · Cited by 147 · see citing works

Ex Vivo IFN-γ Secretion by Circulating CD8 T Lymphocytes: Implications of a Novel Approach for T Cell Monitoring in Infectious and Malignant Diseases

Pittet, M. J., Zippelius, A., Speiser, D. E., Assenmacher, M., Guillaume, P., Valmori, D., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7634 · Cited by 136 · see citing works

Clinical Aspects and Management of Cytomegalovirus Infection

Sissons, J. G. P., & Carmichael, A. J. (2002) · Journal of Infection · doi:10.1053/jinf.2001.0949 · Cited by 132 · see citing works

Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus

Sester, M., Sester, U., Gärtner, B. C., Kubuschok, B., Girndt, M., Meyerhans, A., & Köhler, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3748-3755.2002 · Cited by 122 · see citing works

The Size and Phenotype of Virus-Specific T Cell Populations Is Determined by Repetitive Antigenic Stimulation and Environmental Cytokines

Gamadia, L. E., van Leeuwen, E. M. M., Remmerswaal, E. B. M., Yong, S.-L., Surachno, S., Wertheim-van Dillen, P. M. E., ten Berge, I. J. M., & van Lier, R. A. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6107 · Cited by 122 · see citing works

Dynamics of CD4 and CD8 T Cell Responses to Cytomegalovirus in Healthy Human Donors

Dunn, H. S., Haney, D. J., Ghanekar, S., Stepick‐Biek, P., Lewis, D. B., & Maecker, H. T. (2002) · The Journal of Infectious Diseases · doi:10.1086/341079 · Cited by 116 · see citing works

Human Cytomegalovirus Elicits a Coordinated Cellular Antiviral Response via Envelope Glycoprotein B

Boehme, K. W., Singh, J., Perry, S. T., & Compton, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1202-1211.2004 · Cited by 116 · see citing works

CYTOMEGALOVIRUS PROPHYLAXIS WITH ANTIVIRAL AGENTS IN SOLID ORGAN TRANSPLANTATION

Couchoud, C., Cucherat, M., Haugh, M. C., et al. (1998) · Transplantation · doi:10.1097/00007890-199803150-00007 · Cited by 108 · see citing works

The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation

ter Meulen, C. G., Wetzels, J. F. M., & Hilbrands, L. B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.5.711 · Cited by 105 · see citing works

THE IMPACT OF GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION AFTER LUNG TRANSPLANTATION

Kruger, R. M., Shannon, W. D., Arens, M. Q., et al. (1999) · Transplantation · doi:10.1097/00007890-199911150-00010 · Cited by 98 · see citing works

Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.

Brennan, D. C., Garlock, K., Lippmann, B. A., et al. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v81118 · Cited by 90 · see citing works

COMPARISON OF POLYMERASE CHAIN REACTION FROM PLASMA AND BUFFY COAT WITH ANTIGEN DETECTION AND OCCURRENCE OF IMMUNOGLOBULIN M FOR THE DEMONSTRATION OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION

Schmidt, C. A., OETTLE, H., PENG, R., et al. (1995) · Transplantation · doi:10.1097/00007890-199504000-00010 · Cited by 88 · see citing works

Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients

Toyoda, M., Galfayan, K., Galera, O. A., et al. (1997) · Transplant Immunology · doi:10.1016/s0966-3274(97)80050-0 · Cited by 81 · see citing works

Cytomegalovirus (CMV) Glycoprotein B Genotypes and Response to Antiviral Therapy, in Solid‐Organ–Transplant Recipients with CMV Disease

Humar, A., Kumar, D., Gilbert, C., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377002 · Cited by 80 · see citing works

Escape of Human Cytomegalovirus from HLA-DR-Restricted CD4+T-Cell Response Is Mediated by Repression of Gamma Interferon-Induced Class II Transactivator Expression

Roy, E. L., Mühlethaler‐Mottet, A., Davrinche, C., Mach, B., & Davignon, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6582-6589.1999 · Cited by 80 · see citing works

COMPARATIVE STUDY OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA ASSAY, POLYMERASE CHAIN REACTION, SEROLOGY, AND SHELL VIAL ASSAY IN THE EARLY DIAGNOSIS AND MONITORING OF CMV INFECTION AFTER RENAL TRANSPLANTATION1

Tanabe, K., Tokumoto, T., Ishikawa, N., et al. (1997) · Transplantation · doi:10.1097/00007890-199712270-00016 · Cited by 79 · see citing works

Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients

Storch, G. A., Buller, R. S., Bailey, T. C., et al. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.997-1003.1994 · Cited by 78 · see citing works

The Role of the Tumor Necrosis Factor System and Interleukin‐10 during Cytomegalovirus Infection in Renal Transplant Recipients

Nordøy, I., Müller, F., Nordal, K. P., Rollag, H., Lien, E., Aukrust, P., & Frøland, S. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315184 · Cited by 73 · see citing works

Late and Atypical Cytomegalovirus Disease in Solid‐Organ Transplant Recipients

Slifkin, M., Tempesti, P., Poutsiaka, D. D., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322663 · Cited by 72 · see citing works

Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus

Wang, Z., Rosa, C. L., Maas, R., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.3965-3976.2004 · Cited by 71 · see citing works

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation

Becker, B. N., Becker, Y. T., LEVERSON, G. E., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32793 · Cited by 69 · see citing works

The Association Of The Induction Of Vascular Cell Adhesion Molecule-1 With CytoMEGALOVIRUS ANTIGENEMIA IN HUMAN HEART ALLOGRAFTS

Koskinen, P. (1993) · Transplantation · doi:10.1097/00007890-199311000-00011 · Cited by 69 · see citing works

Occurrence of cytomegalovirus hepatitis in liver transplant patients

Bronsther, O. L., Makowka, L., Jaffe, R., et al. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890240409 · Cited by 67 · see citing works

CYTOMEGALOVIRUS DISEASE RECURRENCE AFTER GANCICLOVIR TREATMENT IN KIDNEY AND KIDNEY-PANCREAS TRANSPLANT RECIPIENTS

Humar, A., Uknis, M. E., Carlone-Jambor, C., et al. (1999) · Transplantation · doi:10.1097/00007890-199901150-00016 · Cited by 66 · see citing works

Monitoring of Alveolar Macrophage Production of Tumor Necrosis Factor-Alpha and Interleukin-6 in Lung Transplant Recipients. Marseille and Montreal Lung Transplantation Group

Magnan, A., Mege, J. L., Reynaud, M., et al. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.3.8087338 · Cited by 57 · see citing works

Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients1

Bonaros, N. E., Kocher, A. A., Dunkler, D., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000119722.37337.dc · Cited by 57 · see citing works

RAT CYTOMEGALOVIRUS INFECTION IN KIDNEY ALLOGRAFT RECIPIENTS IS ASSOCIATED WITH INCREASED EXPRESSION OF INTRACELLULAR ADHESION MOLECULE-1, VASCULAR ADHESION MOLECULE-1, AND THEIR LIGANDS LEUKOCYTE FUNCTION ANTIGEN-1 AND VERY LATE ANTIGEN-4 IN THE GRAFT1

Kloover, J. S., Soots, A. P., Krogerus, L. A., et al. (2000) · Transplantation · doi:10.1097/00007890-200006270-00026 · Cited by 57 · see citing works

CROSS-REACTIVITY OF CYTOMEGALOVIRUS-SPECIFIC CD8+ T CELLS TO ALLO-MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES

Gamadia, L. E., Remmerswaal, E. B. M., Surachno, S., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000131158.81346.64 · Cited by 56 · see citing works

Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors

Slobedman, B., Mocarski, E. S., Arvin, A. M., et al. (2002) · Blood · doi:10.1182/blood.v100.8.2867 · Cited by 49 · see citing works

Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.

Murray, B. M., Amsterdam, D., Gray, V., et al. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891448 · Cited by 45 · see citing works

Cytomegalovirus induces class II expression in rat heart endothelial cells.

Ja, U., Loginov, R. J., Ca, B., et al. (1993) · PubMed · Cited by 36 · see citing works

Anti‐B cell and anti‐cytokine therapy for the treatment of post‐transplant lymphoproliferative disorder: past, present, and future

Durandy, A. (2001) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2001.003002104.x · Cited by 32 · see citing works

Utility of Major Leukocyte Subpopulations for Monitoring Secondary Cytomegalovirus Infections in Renal-Allograft Recipients by PCR

Schafer, P. H., Tenschert, W., Cremaschi, L., Gutensohn, K., & Laufs, R. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1008-1014.1998 · Cited by 25 · see citing works

Skewed maturation of virus-specific CTLs?

Gamadia, L. E., ten Berge, I. J. M., Picker, L. J., & van Lier, R. A. W. (2002) · Nature Immunology · doi:10.1038/ni0302-203 · Cited by 22 · see citing works

Successful and Maladaptive T Cell Aging

Goronzy, J. J., & Weyand, C. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.010 · Cited by 362 · see citing works

Age-Dependent Association between Low Frequency of CD27/CD28 Expression on pp65 CD8⁺T Cells and Cytomegalovirus Replication after Transplantation

Cantisán, S., Torre-Cisneros, J., Lara, R., Rodríguez-Benot, A., Santos, F., Gutiérrez-Aroca, J., Gayoso, I., González-Padilla, M., Casal, M., Rivero, A., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00214-09 · Cited by 27 · see citing works

Identification of human cytomegalovirus isolates by the polymerase chain reaction.

Zipeto, D., Silini, E. M., Parea, M., et al. (1990) · PubMed · Cited by 17 · see citing works

Strategies of control human cytomegalovirus infection

Gu, S. (2002) · Letters in Biotechnology

Human Cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under Ganciclovir therapy

Payan, C., Veal, N., Sarol, L. D. C., et al. (1997) · Journal of Virological Methods · doi:10.1016/s0166-0934(97)02180-0 · Cited by 4 · see citing works

The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients

Fonseca, R. F., Kawamura, M. T., de Oliveira, J. A., et al. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000700020 · Cited by 29 · see citing works

Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus

Kapoor, A., Ghosh, A. K., Forman, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01501 · Cited by 13 · see citing works